MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD – Get Free Report)’s stock price shot up 2.4% on Tuesday . The company traded as high as $1.39 and last traded at $1.34. 12,783 shares traded hands during trading, a decline of 90% from the average session volume of 134,123 shares. The stock had previously closed at $1.31.
MyMD Pharmaceuticals Trading Up 2.4 %
The business has a 50-day moving average price of $1.55 and a two-hundred day moving average price of $1.90.
About MyMD Pharmaceuticals
MyMD Pharmaceuticals, Inc, a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression.
See Also
- Five stocks we like better than MyMD Pharmaceuticals
- What is the S&P 500 and How It is Distinct from Other Indexes
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- How to Most Effectively Use the MarketBeat Earnings Screener
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Using the MarketBeat Dividend Tax Calculator
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for MyMD Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MyMD Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
